Chronic myeloid leukemia, version 2.2021, NCCN clinical practice guidelines in oncology
MW Deininger, NP Shah, JK Altman, E Berman… - Journal of the National …, 2020 - jnccn.org
Chronic myeloid leukemia (CML) is defined by the presence of Philadelphia chromosome
(Ph) which results from a reciprocal translocation between chromosomes 9 and 22 [t (9; 22] …
(Ph) which results from a reciprocal translocation between chromosomes 9 and 22 [t (9; 22] …
Chronic myeloid leukemia, version 1.2019, NCCN clinical practice guidelines in oncology
JP Radich, M Deininger, CN Abboud, JK Altman… - Journal of the National …, 2018 - jnccn.org
Chronic myeloid leukemia (CML) is defined by the presence of Philadelphia chromosome
(Ph), resulting from a reciprocal translocation between chromosomes 9 and 22 [t (9; 22] that …
(Ph), resulting from a reciprocal translocation between chromosomes 9 and 22 [t (9; 22] that …
[HTML][HTML] Monitoring treatment of chronic myeloid leukemia
1Department of Hematology-Oncology" L. and A. Seràgnoli" University of Bologna, Bologna;
2Onco-Hematology Unit, University of Naples Federico II and CEINGE, Biotecnologie …
2Onco-Hematology Unit, University of Naples Federico II and CEINGE, Biotecnologie …
Chronic Myelogenous Leukemia, BCR-ABL1+
JW Vardiman - American journal of clinical pathology, 2009 - academic.oup.com
Session 1 of the 2007 Workshop of the Society for Hematopathology/European Association
for Haematopathology focused on chronic myelogenous leukemia, BCR-ABL1+(CML). CML …
for Haematopathology focused on chronic myelogenous leukemia, BCR-ABL1+(CML). CML …
[HTML][HTML] Ataxia-pancytopenia syndrome is caused by missense mutations in SAMD9L
DH Chen, JE Below, A Shimamura, SB Keel… - The American Journal of …, 2016 - cell.com
Ataxia-pancytopenia (AP) syndrome is characterized by cerebellar ataxia, variable
hematologic cytopenias, and predisposition to marrow failure and myeloid leukemia …
hematologic cytopenias, and predisposition to marrow failure and myeloid leukemia …
Chronic myeloid leukemia, version 2.2024, nccn clinical practice guidelines in oncology
NP Shah, R Bhatia, JK Altman, M Amaya… - Journal of the National …, 2024 - jnccn.org
Chronic myeloid leukemia (CML) is defined by the presence of Philadelphia chromosome
resulting from a reciprocal translocation between chromosomes 9 and 22 [t9; 22] that gives …
resulting from a reciprocal translocation between chromosomes 9 and 22 [t9; 22] that gives …
Clonal chromosomal abnormalities appearing in Philadelphia chromosome–negative metaphases during CML treatment
GC Issa, HM Kantarjian, GN Gonzalez… - Blood, The Journal …, 2017 - ashpublications.org
Clonal chromosomal abnormalities in Philadelphia chromosome-negative (CCA/Ph−)
metaphases emerge as patients with chronic phase chronic myeloid leukemia (CP-CML) are …
metaphases emerge as patients with chronic phase chronic myeloid leukemia (CP-CML) are …
− 7/7q− syndrome in myeloid-lineage hematopoietic malignancies: attempts to understand this complex disease entity
H Honda, A Nagamachi, T Inaba - Oncogene, 2015 - nature.com
The recurrence of chromosomal abnormalities in a specific subtype of cancer strongly
suggests that dysregulated gene expression in the corresponding region has a critical role …
suggests that dysregulated gene expression in the corresponding region has a critical role …
Imatinib-resistant chronic myeloid leukemia (CML): Current concepts on pathogenesis and new emerging pharmacologic approaches
P Valent - Biologics: targets and therapy, 2007 - Taylor & Francis
Chronic myeloid leukemia (CML) is a stem cell disease, in which the BCR/ABL oncoprotein
is considered essential for abnormal growth and accumulation of neoplastic cells. During the …
is considered essential for abnormal growth and accumulation of neoplastic cells. During the …
Emerging stem cell concepts for imatinib‐resistant chronic myeloid leukaemia: implications for the biology, management, and therapy of the disease
P Valent - British journal of haematology, 2008 - Wiley Online Library
Chronic myeloid leukaemia (CML) is a myeloid neoplasm defined by the BCR/ABL
oncoprotein that is considered essential for leukaemogenesis and accumulation of …
oncoprotein that is considered essential for leukaemogenesis and accumulation of …